Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01752166 · ClinicalTrials.gov registry record
Detecting Infections Rapidly and Easily for Candidemia Trial - Part 2 (direcT2 Study)
A clinical trial, sponsored by T2 Biosystems.
- Completed
- Registry status
- 1,500
- Enrollment target
NCT01752166: Completed study, sponsored by T2 Biosystems.
NCT01752166 is a clinical trial that has completed, run by T2 Biosystems. The registered enrollment target is 1,500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01752166 has completed, sponsored by T2 Biosystems.
- COMPLETED
- Registry status
- 1,500 participants
- Enrollment target
Study Summary
The purpose of this study is to validate clinical performance (i.e. estimated sensitivity and specificity) of the T2 Candida test on the T2 DX Instrument compared to blood culture results and/or known Candida positive status of prospectively collected and contrived (i.e. Candida-spiked) clinical specimens.
Primary Outcome
Estimated specificity of the T2Candida test will be examined by comparing T2Candida test results from prospectively collected T2 clinical specimens to blood culture results from specimens that are culture negative for Candida and which have been collected at the same time and from the same anatomical location as the T2 specimens.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-04 |
What the finished NCT01752166 record still lists
NCT01752166 is an observational study that tracks outcomes without assigning an intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01752166 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01752166 about?
NCT01752166 is a clinical study titled "Detecting Infections Rapidly and Easily for Candidemia Trial - Part 2 (direcT2 Study)". The purpose of this study is to validate clinical performance (i.e. estimated sensitivity and specificity) of the T2 Candida test on the T2 DX Instrument compared to blood culture results and/or known Candida positive status of prospectively collected and contrived (i.e. Candida-spiked) clinical spe...
What is the current status of trial NCT01752166?
This trial is currently completed. The enrollment target is 1,500 participants. The study started on 2013-07. Estimated completion is 2014-04.
Who is sponsoring clinical trial NCT01752166?
This trial is sponsored by T2 Biosystems, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia